Common variation in NOS1AP and KCNH2 genes and QT interval duration in young adults. The Cardiovascular Risk in Young Finns Study

References

• Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation. 1991; 83: 1888–94
   PubMed Web of Science ®Google Scholar
• Dekker JM, Crow RS, Hannan PJ, Schouten EG, Folsom AR. Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: the ARIC study. J Am Coll Cardiol. 2004; 43: 565–71
   PubMed Web of Science ®Google Scholar
• Dekker JM, Schouten EG, Klootwijk P, Pool J, Kromhout D. Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study. Circulation. 1994; 90: 779–85
   PubMed Web of Science ®Google Scholar
• Newton-Cheh C, Larson MG, Corey DC, Benjamin EJ, Herbert AG, Levy D, et al. QT interval is a heritable quantitative trait with evidence of linkage to chromosome 3 in a genome-wide linkage analysis: The Framingham Heart Study. Heart Rhythm. 2005; 2: 277–84
   PubMed Web of Science ®Google Scholar
• Mangoni AA, Kinirons MT, Swift CG, Jackson SH. Impact of age on QT interval and QT dispersion in healthy subjects: a regression analysis. Age Ageing. 2003; 32: 326–31
   PubMed Web of Science ®Google Scholar
• Testai L, Bianucci AM, Massarelli I, Breschi MC, Martinotti E, Calderone V. Torsadogenic cardiotoxicity of antipsychotic drugs: a structural feature, potentially involved in the interaction with cardiac HERG potassium channels. Curr Med Chem. 2004; 11: 2691–706
   PubMed Web of Science ®Google Scholar
• Pfeufer A, Jalilzadeh S, Perz S, Mueller JC, Hinterseer M, Illig T, et al. Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study. Circ Res. 2005; 96: 693–701
   PubMed Web of Science ®Google Scholar
• Priori SG, Napolitano C. Genetics of cardiac arrhythmias and sudden cardiac death. Ann N Y Acad Sci. 2004; 1015: 96–110
   Google Scholar
• Friedlander Y, Lapidos T, Sinnreich R, Kark JD. Genetic and environmental sources of QT interval variability in Israeli families: the kibbutz settlements family study. Clin Genet. 1999; 56: 200–9
   Google Scholar
• Hong Y, Rautaharju PM, Hopkins PN, Arnett DK, Djousse L, Pankow JS, et al. Familial aggregation of QT-interval variability in a general population: results from the NHLBI Family Heart Study. Clin Genet. 2001; 59: 171–7
   Google Scholar
• Arking DE, Pfeufer A, Post W, Kao WH, Newton-Cheh C, Ikeda M, et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet. 2006; 38: 644–51
   PubMed Web of Science ®Google Scholar
• Post W, Shen H, Damcott C, Arking DE, Kao WH, Sack PA, et al. Associations between genetic variants in the NOS1AP (CAPON) gene and cardiac repolarization in the old order Amish. Hum Hered. 2007; 64: 214–9
   PubMedGoogle Scholar
• Aarnoudse AJ, Newton-Cheh C, de Bakker PI, Straus SM, Kors JA, Hofman A, et al. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study. Circulation. 2007; 116: 10–6
   PubMedGoogle Scholar
• Laitinen P, Fodstad H, Piippo K, Swan H, Toivonen L, Viitasalo M, et al. Survey of the coding region of the HERG gene in long QT syndrome reveals six novel mutations and an amino acid polymorphism with possible phenotypic effects. Hum Mutat. 2000; 15: 580–1
   PubMedGoogle Scholar
• Pietilä E, Fodstad H, Niskasaari E, Laitinen PP, Swan H, Savolainen M, et al. Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women. J Am Coll Cardiol. 2002; 40: 511–4
   PubMedGoogle Scholar
• Bezzina CR, Verkerk AO, Busjahn A, Jeron A, Erdmann J, Koopmann TT, et al. A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization. Cardiovasc Res. 2003; 59: 27–36
   PubMed Web of Science ®Google Scholar
• Gouas L, Nicaud V, Berthet M, Forhan A, Tiret L, Balkau B, et al. Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population. Eur J Hum Genet. 2005; 13: 1213–22
   PubMed Web of Science ®Google Scholar
• Newton-Cheh C, Guo CY, Larson MG, Musone SL, Surti A, Camargo AL, et al. Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham Heart Study. Circulation. 2007; 116: 1128–36
   PubMed Web of Science ®Google Scholar
• Koskela J, Laiho J, Kähönen M, Rontu R, Lehtinen R, Viik J, et al. Potassium channel KCNH2 K897T polymorphism and cardiac repolarization during exercise test: The Finnish Cardiovascular Study. Scand J Clin Lab Invest. 2008; 68: 31–8
   PubMed Web of Science ®Google Scholar
• Åkerblom HK, Viikari J, Uhari M, Räsänen L, Byckling T, Louhivuori K, et al. Atherosclerosis precursors in Finnish children and adolescents. I. General description of the cross-sectional study of 1980, and an account of the children's and families’ state of health. Acta Paediatr Scand Suppl. 1985; 318: 49–63
   PubMedGoogle Scholar
• Raitakari OT, Porkka KV, Räsänen L, Rönnemaa T, Viikari JS. Clustering and six year cluster-tracking of serum total cholesterol, HDL-cholesterol and diastolic blood pressure in children and young adults. The Cardiovascular Risk in Young Finns Study. J Clin Epidemiol. 1994; 47: 1085–93
   PubMed Web of Science ®Google Scholar
• Åkerblom HK, Viikari J, Raitakari OT, Uhari M. Cardiovascular Risk in Young Finns Study: general outline and recent developments. Ann Med 1999; 1(31 Suppl)45–54
   Google Scholar
• Raitakari OT, Juonala M, Kähönen M, Taittonen L, Laitinen T, Mäki-Torkko N, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood—The Cardiovascular Risk in Young Finns Study. JAMA. 2003; 290: 2277–83
   PubMed Web of Science ®Google Scholar
• Juonala M, Viikari JS, Hutri-Kähönen N, Pietikäinen M, Jokinen E, Taittonen L, et al. The 21-year follow-up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east-west difference. J Intern Med. 2004; 255: 457–68
   PubMed Web of Science ®Google Scholar
• World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res. 1997;35:2–3.
   PubMed Web of Science ®Google Scholar
• Viikari J, Rönnemaa T, Seppänen A, Marniemi J, Porkka K, Räsänen L, et al. Serum lipids and lipoproteins in children, adolescents and young adults in 1980–1986. Ann Med. 1991; 23: 53–9
   PubMed Web of Science ®Google Scholar
• Porkka KV, Raitakari OT, Leino A, Laitinen S, Räsänen L, Rönnemaa T, et al. Trends in serum lipid levels during 1980–1992 in children and young adults. The Cardiovascular Risk in Young Finns Study. Am J Epidemiol. 1997; 146: 64–77
   PubMed Web of Science ®Google Scholar
• Bazett H. An analysis of time relations of the electrocardiogram. Heart. 1920; 7: 807–23
   Google Scholar
• Fridericia L. Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken. Acta Med Scand. 1920; 7: 469–86
   Google Scholar
• Livak KJ. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal. 1999; 14: 143–9
   PubMedGoogle Scholar
• US Department of Health and Human Services Food and Drug Administration. Guidance for Industry: E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs. Rockville, MD: Food and Drug Administration; 2005. p. 1–16.
   Google Scholar
• Jaffrey SR, Snowman AM, Eliasson MJ, Cohen NA, Snyder SH. CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95. Neuron. 1998; 20: 115–24
   PubMed Web of Science ®Google Scholar
• Sears CE, Ashley EA, Casadei B. Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component?. Philos Trans R Soc Lond B Biol Sci. 2004; 359: 1021–44
   PubMed Web of Science ®Google Scholar
• Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature. 2002; 416: 337–9
   PubMed Web of Science ®Google Scholar
• Burkard N, Rokita AG, Kaufmann SG, Hallhuber M, Wu R, Hu K, et al. Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility. Circ Res. 2007; 100: e32–44
   Google Scholar
• Li D, Wang L, Lee CW, Dawson TA, Paterson DJ. Noradrenergic cell specific gene transfer with neuronal nitric oxide synthase reduces cardiac sympathetic neurotransmission in hypertensive rats. Hypertension. 2007; 50: 69–74
   Google Scholar
• Paton JF, Kasparov S, Paterson DJ. Nitric oxide and autonomic control of heart rate: a question of specificity. Trends Neurosci. 2002; 25: 626–31
   PubMed Web of Science ®Google Scholar
• Herring N, Paterson D. Letter to the Editor. Circulation. 2007; 116: e564
   Google Scholar
• Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell. 1995; 81: 299–307
   PubMed Web of Science ®Google Scholar
• Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL, et al. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation. 2000; 102: 1178–85
   PubMed Web of Science ®Google Scholar
• Rautaharju PM, Zhou SH, Wong S, Calhoun HP, Berenson GS, Prineas R, et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol. 1992; 8: 690–5
   PubMed Web of Science ®Google Scholar
• Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA. 1993; 270: 2590–7
   PubMed Web of Science ®Google Scholar
• Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, et al. Risk stratification in the long-QT syndrome. N Engl J Med. 2003; 348: 1866–74
   PubMed Web of Science ®Google Scholar
• Tester DJ, Ackerman MJ. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. J Am Coll Cardiol. 2007; 49: 240–6
   PubMed Web of Science ®Google Scholar
• Malik M. Problems of heart rate correction in assessment of drug-induced QT interval prolongation. J Cardiovasc Electrophysiol. 2001; 12: 411–20
   PubMed Web of Science ®Google Scholar
• Dalageorgou C, Ge D, Jamshidi Y, Nolte IM, Riese H, Savelieva I, et al. Heritability of QT Interval: how much is explained by genes for resting heart rate?. J Cardiovasc Electrophysiol. 2008; 19: 386–91
   Google Scholar